# Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea

> **NCT02630121** · PHASE4 · RECRUITING · sponsor: **University of South Florida** · enrollment: 52 (estimated)

## Conditions studied

- Sleep Apnea
- Chronic Nasal Congestion

## Interventions

- **DRUG:** Oxymetazoline Hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02630121
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-01
- **Primary completion:** 2026-04
- **Final completion:** 2026-04
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2025-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02630121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02630121, "Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02630121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*